ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 61 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,051 | +33.5% | 89,367 | +41.5% | 0.00% | – |
| Q2 2023 | $100,409 | +50.3% | 63,150 | -32.2% | 0.00% | – |
| Q1 2023 | $66,826 | +3561.7% | 93,150 | +2857.1% | 0.00% | – |
| Q4 2022 | $1,825 | -8.8% | 3,150 | +57.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 2,000 | -16.7% | 0.00% | – |
| Q2 2021 | $8,000 | -66.7% | 2,400 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | -7.7% | 2,400 | 0.0% | 0.00% | – |
| Q4 2020 | $26,000 | +4.0% | 2,400 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -50.0% | 2,400 | 0.0% | 0.00% | – |
| Q2 2020 | $50,000 | +108.3% | 2,400 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |